Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma

• Main Authors: Yu-Ting Ma (Author), Yan Li (Author), Li Yan (Author), Fang Hua (Author), Dong-Guan Wang (Author), Guo-Ying Xu (Author), Hong-Lan Yang (Author), Ying-Jie Xue (Author), Ye-Jun Qin (Author), Dan Sha (Author), Hao Ning (Author), Miao-Qing Zhao (Author), Zhi-Gang Yao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immune checkpoint inhibitors (ICIs) have shown encouraging outcomes against Lynch syndrome (LS)-associated colorectal cancer (CRC) and endometrial cancer with mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H). However, there is as yet no clarity on the safety and efficacy of imm...